SCOPUS 정보 검색 플랫폼

Volumn 31, Issue 3, 2014, Pages 364-367

Developing microphysiological systems for use as regulatory tools - Challenges and opportunities

(15) Andersen, Melvin E a Betts, Kellyn b Dragan, Yvonne c Fitzpatrick, Suzanne d Goodman, Jesse L d Hartung, Thomas e Himmelfarb, Jonathan f Ingber, Donald E g Jacobs, Abigail d Kavlock, Robert h Kolaja, Kyle i Stevens, James L j Tagle, Dan k Taylor, D Lansing l Throckmorton, Douglas d

a HAMNER INSTITUTES FOR HEALTH SCIENCES (United States)

b AstraZeneca ^* (United States)

c ASTRAZENECA (United Kingdom)

d CENTER FOR DRUG EVALUATION AND RESEARCH (United States)

e JOHNS HOPKINS UNIVERSITY (United States)

f UNIVERSITY OF WASHINGTON (United States)

g HARVARD UNIVERSITY (United States)

h U S ENVIRONMENTAL PROTECTION AGENCY (United States)

i Cellular Dynamics International Inc (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; PHYSIOLOGY; PRACTICE GUIDELINE; QUALITY CONTROL; TOXICITY TESTING; ANIMAL TESTING ALTERNATIVE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; LAB ON A CHIP; LEGISLATION AND JURISPRUDENCE; MICROFLUIDIC ANALYSIS; PROCEDURES; RISK ASSESSMENT; TRENDS; UNITED STATES;

ANIMAL TESTING ALTERNATIVES; GOVERNMENT REGULATION; LAB-ON-A-CHIP DEVICES; MICROFLUIDIC ANALYTICAL TECHNIQUES; RISK ASSESSMENT; TOXICITY TESTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84904901205 PISSN: 1868596X EISSN: 18688551 Source Type: Journal
DOI: 10.14573/altex.1405151 Document Type: Conference Paper

Times cited : (32)

References (6)

1
- 79955601786
- Trial watch: Phase II failures: 2008-2010
- Arrowsmith, J. (2011). Trial watch: Phase II failures: 2008-2010. Nat Rev Drug Discov 10, 328-329. http://dx.doi.org/10.1038/nrd3439
- (2011) Nat Rev Drug Discov , vol.10 , pp. 328-329
- Arrowsmith, J.¹

2
- 77954038080
- Reconstituting organ-level lung functions on a chip
- Huh, D., Matthews, B. D., Mammoto, A. et al. (2010). Reconstituting organ-level lung functions on a chip. Science 328, 1662-1668. http://dx.doi.org/10.1126/science.1188302
- (2010) Science , vol.328 , pp. 1662-1668
- Huh, D.¹ Matthews, B.D.² Mammoto, A.³

3
- 84869126274
- A human disease model of drug toxicity - induced pulmonary edema in a lung-on-a-chip microdevice
- Huh, D., Leslie, D. C., Matthews, B. D. et al. (2012). A human disease model of drug toxicity - induced pulmonary edema in a lung-on-a-chip microdevice. Sci Trans Med 4, 159ra147. http://dx.doi.org/10.1126/scitranslmed. 3004249
- (2012) Sci Trans Med , vol.4
- Huh, D.¹ Leslie, D.C.² Matthews, B.D.³

4
- 84862207235
- Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow
- Kim, H. J., Huh, D., Hamilton, G. and Ingber, D. E. (2012). Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12, 2165-2174. http://dx.doi.org/10. 1039/C2LC40074J
- (2012) Lab Chip , vol.12 , pp. 2165-2174
- Kim, H.J.¹ Huh, D.² Hamilton, G.³ Ingber, D.E.⁴

5
- 84882627623
- Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation
- Kim, H. J. and Ingber, D. E. (2013). Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr Biol (Camb) 5, 1130-1140. http://dx.doi.org/10.1039/c3ib40126j
- (2013) Integr Biol (Camb) , vol.5 , pp. 1130-1140
- Kim, H.J.¹ Ingber, D.E.²

6
- 4344645978
- Can the pharmaceutical industry reduce attrition rates?
- Kola, I. and Landis, J. (2004). Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3, 711-716. http://dx.doi.org/10.1038/ nrd1470
- (2004) Nat Rev Drug Discov , vol.3 , pp. 711-716
- Kola, I.¹ Landis, J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.